Antimicrobial Agents and Chemotherapy · 2021 · 24 citations · 28 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceMicrobial GeneticsPharmacogeneticsAntibacterial ResistanceAntibiotic ResistanceAntibiotic Resistance GeneticsAntimicrobial Resistance GenomicsDrug Resistance GenomicsResistance GenesLong-read SequencingLoss-of-function MutationsLoss-of-function Receptor MutationsMolecular Drug ResistanceMolecular Drug Susceptibility TestingMycobacterium Tuberculosis InfectionResistance In Clinical IsolatesTuberculosis Drug Resistance
Pyrazinamide (PZA) is a widely used antitubercular chemotherapeutic. Typically, PZA resistance (PZA-R) emerges in Mycobacterium tuberculosis strains with existing resistance to isoniazid and rifampin (i.e., multidrug resistance [MDR]) and is conferred by loss-of-function pncA mutations that inhibit conversion to its active form, pyrazinoic acid (POA).
28
The Ensembl Variant Effect Predictor
William McLaren, Laurent Gil, Sarah Hunt et al. · Genome biology · 2016 · 8.7K citations · Full text